
Read the latest PLC CEO interviews. CEO’s from UK listed PLC’s, Analysts and Fund Managers answering questions about their business.
Goodbody Health Inc (AQSE:GDBY) Scientific Advisory Committee Member Dr Jamie Brosch caught up with DirectorsTalk for an exclusive interview to discuss his background as a GP, how the company’s partnership..
CyanConnode Holdings plc (LON:CYAN) is the topic of conversation when Hardman and Co’s Technology Analyst Milan Radia caught up with DirectorsTalk for an exclusive interview. Q1: We’ve spoken about CyanConnode..
City of London Investment Group plc (LON:CLIG) is the topic of conversation when Zeus Capital’s Research Director Robin Savage caught up with DirectorsTalk for an exclusive interview. Q1: City of..
Helium One Global Ltd (LON:HE1) Chief Executive Officer David Minchin caught up with DirectorsTalk for an exclusive interview to discuss 2021 achievements, the exploration programme, what investors should be looking..
Aferian plc (LON:AFRN) Chief Executive Officer Donald McGarva caught up with DirectorsTalk for an exclusive interview to discuss group performance in 2021, progress in its 2025 strategy goals, what we..
Zinc Media Group plc (LON:ZIN) Chief Executive Officer Mark Browning caught up with DirectorsTalk for an exclusive interview to discuss what the company does, its typical clients, highlights from their..
Fidelity Japan Trust plc (LON:FJV) is the topic of conversation when Hardman and Co’s Analyst Mark Thomas caught up with DirectorsTalk for an exclusive interview. Q1: You called your recent..
CentralNic Group plc (LON:CNIC) is the topic of conversation when Zeus Capital’s Technology Analyst Bob Liao caught up with DirectorsTalk for an exclusive interview. Q1: CentralNic Group announced a strong..
Cizzle Biotechnology Holdings plc (LON:CIZ) Executive Chairman Allan Syms caught up with DirectorsTalk for an exclusive interview to discuss acquiring 5% economic interest of AZD 1656, what it is and..
Dekel Agri-Vision plc (LON:DKL) Executive Director Lincoln Moore caught up with DirectorsTalk for an exclusive interview to discuss the strong start to the high season, strong CPO prices, why PKO..
Vector Capital plc (LON:VCAP) Chief Executive Officer Agam Jain caught up with DirectorsTalk for an exclusive interview to discuss what the company does, products & services it offers, highlights from,..
Goodbody Health Group Inc (AQSE:GDBY) subsidiary PhytoVista Laboratories Chief Scientific Officer Nick Clarkson caught up with DirectorsTalk for an exclusive interview to discuss the extension of the scope of ISO..
itim Group plc (LON:ITIM) Founder and Chief Executive Officer Ali Athar caught up with DirectorsTalk for an exclusive interview to discuss what the company does, its typical customers, its impressive..
Cadence Minerals plc (LON:KDNC) Chief Executive Officer Kiran Morzaria caught up with DirectorsTalk for an exclusive interview to discuss the completion of phase one of their investment in the Amapá..
Strix Group plc (LON:KETL) is the topic of conversation when Zeus Capital’s Research Director Andy Hanson caught up with DirectorsTalk for an exclusive interview. Q1: Strix Group have released a..
Cizzle Biotechnology Holdings plc (LON:CIZ) Executive Chairman Allan Syms caught up with DirectorsTalk for an exclusive interview to discuss the commercial and royalty agreement to develop and market their early..
Open Orphan plc (LON:ORPH) Executive Chairman Cathal Friel caught up with DirectorsTalk for an exclusive interview to discuss the results from the COVID-19 characterisation study, the next phase of the..
Tirupati Graphite plc (LON:TGR) Executive Chairman and Managing Director Shishir Poddar caught up with DirectorsTalk for an exclusive interview to discuss hitting production targets and what it’ll mean for the..
Quadrise Fuels International plc (LON:QFI) Chief Executive Officer Jason Miles caught up with DirectorsTalk for an exclusive interview to discuss new Chairman Andy Morrison, the significant for bioMSAR as a..
Fintel plc (LON:FNTL) is the topic of conversation when Zeus Capital’s Research Analyst Robin Savage caught up with DirectorsTalk for an exclusive interview. Q1: Robin, what were the key points..



























